Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The Potential Role of Social Media Platforms in Community Awareness of Antibiotic Use in the Gulf Cooperation Council States: Luxury or Necessity?

Identifieur interne : 001436 ( PubMed/Curation ); précédent : 001435; suivant : 001437

The Potential Role of Social Media Platforms in Community Awareness of Antibiotic Use in the Gulf Cooperation Council States: Luxury or Necessity?

Auteurs : Hosam Mamoon Zowawi [Australie] ; Malak Abedalthagafi ; Florie A. Mar ; Turki Almalki ; Abdullah H. Kutbi ; Tiffany Harris-Brown ; Stephan Harbarth ; Hanan H. Balkhy ; David L. Paterson ; Rihab Abdalazez Hasanain

Source :

RBID : pubmed:26471079

Descripteurs français

English descriptors

Abstract

The increasing emergence and spread of antimicrobial resistance (AMR) is a serious public health issue. Increasing the awareness of the general public about appropriate antibiotic use is a key factor for combating this issue. Several public media campaigns worldwide have been launched; however, such campaigns can be costly and the outcomes are variable and difficult to assess. Social media platforms, including Twitter, Facebook, and YouTube, are now frequently utilized to address health-related issues. In many geographical locations, such as the countries of the Gulf Cooperation Council (GCC) States (Saudi Arabia, United Arab Emirates, Kuwait, Oman, Qatar, and Bahrain), these platforms are becoming increasingly popular. The socioeconomic status of the GCC states and their reliable communication and networking infrastructure has allowed the penetration and scalability of these platforms in the region. This might explain why the Saudi Ministry of Health is using social media platforms alongside various other media platforms in a large-scale public awareness campaign to educate at-risk communities about the recently emerged Middle East respiratory syndrome coronavirus (MERS-CoV). This paper discusses the potential for using social media tools as cost-efficient and mass education platforms to raise awareness of appropriate antibiotic use in the general public and in the medical communities of the Arabian Peninsula.

DOI: 10.2196/jmir.3891
PubMed: 26471079

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:26471079

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The Potential Role of Social Media Platforms in Community Awareness of Antibiotic Use in the Gulf Cooperation Council States: Luxury or Necessity?</title>
<author>
<name sortKey="Zowawi, Hosam Mamoon" sort="Zowawi, Hosam Mamoon" uniqKey="Zowawi H" first="Hosam Mamoon" last="Zowawi">Hosam Mamoon Zowawi</name>
<affiliation wicri:level="1">
<nlm:affiliation>The University of Queensland, UQ Centre for Clinical Research, Herston QLD 4029, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The University of Queensland, UQ Centre for Clinical Research, Herston QLD 4029</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Abedalthagafi, Malak" sort="Abedalthagafi, Malak" uniqKey="Abedalthagafi M" first="Malak" last="Abedalthagafi">Malak Abedalthagafi</name>
</author>
<author>
<name sortKey="Mar, Florie A" sort="Mar, Florie A" uniqKey="Mar F" first="Florie A" last="Mar">Florie A. Mar</name>
</author>
<author>
<name sortKey="Almalki, Turki" sort="Almalki, Turki" uniqKey="Almalki T" first="Turki" last="Almalki">Turki Almalki</name>
</author>
<author>
<name sortKey="Kutbi, Abdullah H" sort="Kutbi, Abdullah H" uniqKey="Kutbi A" first="Abdullah H" last="Kutbi">Abdullah H. Kutbi</name>
</author>
<author>
<name sortKey="Harris Brown, Tiffany" sort="Harris Brown, Tiffany" uniqKey="Harris Brown T" first="Tiffany" last="Harris-Brown">Tiffany Harris-Brown</name>
</author>
<author>
<name sortKey="Harbarth, Stephan" sort="Harbarth, Stephan" uniqKey="Harbarth S" first="Stephan" last="Harbarth">Stephan Harbarth</name>
</author>
<author>
<name sortKey="Balkhy, Hanan H" sort="Balkhy, Hanan H" uniqKey="Balkhy H" first="Hanan H" last="Balkhy">Hanan H. Balkhy</name>
</author>
<author>
<name sortKey="Paterson, David L" sort="Paterson, David L" uniqKey="Paterson D" first="David L" last="Paterson">David L. Paterson</name>
</author>
<author>
<name sortKey="Hasanain, Rihab Abdalazez" sort="Hasanain, Rihab Abdalazez" uniqKey="Hasanain R" first="Rihab Abdalazez" last="Hasanain">Rihab Abdalazez Hasanain</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26471079</idno>
<idno type="pmid">26471079</idno>
<idno type="doi">10.2196/jmir.3891</idno>
<idno type="wicri:Area/PubMed/Corpus">001436</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001436</idno>
<idno type="wicri:Area/PubMed/Curation">001436</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001436</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The Potential Role of Social Media Platforms in Community Awareness of Antibiotic Use in the Gulf Cooperation Council States: Luxury or Necessity?</title>
<author>
<name sortKey="Zowawi, Hosam Mamoon" sort="Zowawi, Hosam Mamoon" uniqKey="Zowawi H" first="Hosam Mamoon" last="Zowawi">Hosam Mamoon Zowawi</name>
<affiliation wicri:level="1">
<nlm:affiliation>The University of Queensland, UQ Centre for Clinical Research, Herston QLD 4029, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The University of Queensland, UQ Centre for Clinical Research, Herston QLD 4029</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Abedalthagafi, Malak" sort="Abedalthagafi, Malak" uniqKey="Abedalthagafi M" first="Malak" last="Abedalthagafi">Malak Abedalthagafi</name>
</author>
<author>
<name sortKey="Mar, Florie A" sort="Mar, Florie A" uniqKey="Mar F" first="Florie A" last="Mar">Florie A. Mar</name>
</author>
<author>
<name sortKey="Almalki, Turki" sort="Almalki, Turki" uniqKey="Almalki T" first="Turki" last="Almalki">Turki Almalki</name>
</author>
<author>
<name sortKey="Kutbi, Abdullah H" sort="Kutbi, Abdullah H" uniqKey="Kutbi A" first="Abdullah H" last="Kutbi">Abdullah H. Kutbi</name>
</author>
<author>
<name sortKey="Harris Brown, Tiffany" sort="Harris Brown, Tiffany" uniqKey="Harris Brown T" first="Tiffany" last="Harris-Brown">Tiffany Harris-Brown</name>
</author>
<author>
<name sortKey="Harbarth, Stephan" sort="Harbarth, Stephan" uniqKey="Harbarth S" first="Stephan" last="Harbarth">Stephan Harbarth</name>
</author>
<author>
<name sortKey="Balkhy, Hanan H" sort="Balkhy, Hanan H" uniqKey="Balkhy H" first="Hanan H" last="Balkhy">Hanan H. Balkhy</name>
</author>
<author>
<name sortKey="Paterson, David L" sort="Paterson, David L" uniqKey="Paterson D" first="David L" last="Paterson">David L. Paterson</name>
</author>
<author>
<name sortKey="Hasanain, Rihab Abdalazez" sort="Hasanain, Rihab Abdalazez" uniqKey="Hasanain R" first="Rihab Abdalazez" last="Hasanain">Rihab Abdalazez Hasanain</name>
</author>
</analytic>
<series>
<title level="j">Journal of medical Internet research</title>
<idno type="eISSN">1438-8871</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Health Promotion (statistics & numerical data)</term>
<term>Humans</term>
<term>Middle East</term>
<term>Social Media (statistics & numerical data)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antibactériens (usage thérapeutique)</term>
<term>Humains</term>
<term>Moyen Orient</term>
<term>Médias sociaux ()</term>
<term>Promotion de la santé ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Health Promotion</term>
<term>Social Media</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antibactériens</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Middle East</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Moyen Orient</term>
<term>Médias sociaux</term>
<term>Promotion de la santé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The increasing emergence and spread of antimicrobial resistance (AMR) is a serious public health issue. Increasing the awareness of the general public about appropriate antibiotic use is a key factor for combating this issue. Several public media campaigns worldwide have been launched; however, such campaigns can be costly and the outcomes are variable and difficult to assess. Social media platforms, including Twitter, Facebook, and YouTube, are now frequently utilized to address health-related issues. In many geographical locations, such as the countries of the Gulf Cooperation Council (GCC) States (Saudi Arabia, United Arab Emirates, Kuwait, Oman, Qatar, and Bahrain), these platforms are becoming increasingly popular. The socioeconomic status of the GCC states and their reliable communication and networking infrastructure has allowed the penetration and scalability of these platforms in the region. This might explain why the Saudi Ministry of Health is using social media platforms alongside various other media platforms in a large-scale public awareness campaign to educate at-risk communities about the recently emerged Middle East respiratory syndrome coronavirus (MERS-CoV). This paper discusses the potential for using social media tools as cost-efficient and mass education platforms to raise awareness of appropriate antibiotic use in the general public and in the medical communities of the Arabian Peninsula. </div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
<PMID Version="1">26471079</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>05</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1438-8871</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>17</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Journal of medical Internet research</Title>
<ISOAbbreviation>J. Med. Internet Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>The Potential Role of Social Media Platforms in Community Awareness of Antibiotic Use in the Gulf Cooperation Council States: Luxury or Necessity?</ArticleTitle>
<Pagination>
<MedlinePgn>e233</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2196/jmir.3891</ELocationID>
<Abstract>
<AbstractText>The increasing emergence and spread of antimicrobial resistance (AMR) is a serious public health issue. Increasing the awareness of the general public about appropriate antibiotic use is a key factor for combating this issue. Several public media campaigns worldwide have been launched; however, such campaigns can be costly and the outcomes are variable and difficult to assess. Social media platforms, including Twitter, Facebook, and YouTube, are now frequently utilized to address health-related issues. In many geographical locations, such as the countries of the Gulf Cooperation Council (GCC) States (Saudi Arabia, United Arab Emirates, Kuwait, Oman, Qatar, and Bahrain), these platforms are becoming increasingly popular. The socioeconomic status of the GCC states and their reliable communication and networking infrastructure has allowed the penetration and scalability of these platforms in the region. This might explain why the Saudi Ministry of Health is using social media platforms alongside various other media platforms in a large-scale public awareness campaign to educate at-risk communities about the recently emerged Middle East respiratory syndrome coronavirus (MERS-CoV). This paper discusses the potential for using social media tools as cost-efficient and mass education platforms to raise awareness of appropriate antibiotic use in the general public and in the medical communities of the Arabian Peninsula. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zowawi</LastName>
<ForeName>Hosam Mamoon</ForeName>
<Initials>HM</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-9718-6475</Identifier>
<AffiliationInfo>
<Affiliation>The University of Queensland, UQ Centre for Clinical Research, Herston QLD 4029, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abedalthagafi</LastName>
<ForeName>Malak</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-1786-3366</Identifier>
</Author>
<Author ValidYN="Y">
<LastName>Mar</LastName>
<ForeName>Florie A</ForeName>
<Initials>FA</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-8342-5976</Identifier>
</Author>
<Author ValidYN="Y">
<LastName>Almalki</LastName>
<ForeName>Turki</ForeName>
<Initials>T</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-7540-8954</Identifier>
</Author>
<Author ValidYN="Y">
<LastName>Kutbi</LastName>
<ForeName>Abdullah H</ForeName>
<Initials>AH</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-8964-1052</Identifier>
</Author>
<Author ValidYN="Y">
<LastName>Harris-Brown</LastName>
<ForeName>Tiffany</ForeName>
<Initials>T</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-1229-7863</Identifier>
</Author>
<Author ValidYN="Y">
<LastName>Harbarth</LastName>
<ForeName>Stephan</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-3551-1025</Identifier>
</Author>
<Author ValidYN="Y">
<LastName>Balkhy</LastName>
<ForeName>Hanan H</ForeName>
<Initials>HH</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-6968-2834</Identifier>
</Author>
<Author ValidYN="Y">
<LastName>Paterson</LastName>
<ForeName>David L</ForeName>
<Initials>DL</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-0826-0654</Identifier>
</Author>
<Author ValidYN="Y">
<LastName>Hasanain</LastName>
<ForeName>Rihab Abdalazez</ForeName>
<Initials>RA</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-8757-8398</Identifier>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>J Med Internet Res</MedlineTA>
<NlmUniqueID>100959882</NlmUniqueID>
<ISSNLinking>1438-8871</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006293" MajorTopicYN="N">Health Promotion</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008877" MajorTopicYN="N">Middle East</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D061108" MajorTopicYN="N">Social Media</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Gulf States</Keyword>
<Keyword MajorTopicYN="N">antibiotics</Keyword>
<Keyword MajorTopicYN="N">awareness</Keyword>
<Keyword MajorTopicYN="N">health campaigns</Keyword>
<Keyword MajorTopicYN="N">social media</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>06</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2015</Year>
<Month>06</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>10</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>10</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>5</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26471079</ArticleId>
<ArticleId IdType="pii">v17i10e233</ArticleId>
<ArticleId IdType="doi">10.2196/jmir.3891</ArticleId>
<ArticleId IdType="pmc">PMC4642378</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>New Microbiol. 2011 Jul;34(3):291-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21811750</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2002 Apr;8(4):347-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11971765</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Cancer. 2013 Oct 29;13:508</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24168075</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2010 Jan;10(1):17-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20129146</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Antimicrob Chemother. 2010 Jul;65(7):1526-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20488985</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMJ. 2013 Sep 12;347:f5391</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24030722</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Pharm World Sci. 2010 Oct;32(5):643-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20640511</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Med. 2009 Jun 2;6(6):e1000084</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19492093</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Cancer Educ. 2016 Sep;31(3):559-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25903054</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Health Promot. 2016 Mar;30(4):283-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27404065</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Public Health. 2014 Jan 23;14:73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24456730</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Infect Control. 2004 Dec;32(8):470-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15573054</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2009 Jul 30;14(30):19280</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19643056</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Microbiol Rev. 2015 Apr;28(2):465-522</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25810418</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Saudi Med J. 2013 Aug;34(8):832-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23974456</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Dis Poverty. 2013 Dec 02;2(1):29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24289667</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Antimicrob Chemother. 2011 Jun;66 Suppl 5:v3-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21680584</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Internet Res. 2013 Feb 13;15(2):e30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23406655</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Microbiol Rev. 2013 Jul;26(3):361-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23824364</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Med. 2009 Jun 2;6(6):e1000080</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19492081</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Internet Res. 2014 Feb 14;16(2):e40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24550083</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2008 Nov 13;13(46):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19021954</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18254058</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Med Care. 2008 Jun;46(6):597-605</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18520314</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Public Health. 2011 Oct 19;11:816</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22011332</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2013 Apr 25;368(17):1603-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23614586</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>JMIR Res Protoc. 2014 Nov 12;3(4):e64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25405494</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Saudi Med J. 2013 Oct;34(10):1048-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24145940</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2004 Mar;10(3):514-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15109426</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dev Ctries. 2009 Aug 30;3(7):491-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19762966</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Dermatol Clin. 2009 Apr;27(2):133-6, vi</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19254656</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 2010 Jan;54(1):109-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19841152</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Public Health. 2011 Jul 07;11:538</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21736711</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Health Educ Behav. 2004 Apr;31(2):143-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15090118</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Internet Res. 2011 Jan 17;13(1):e7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21247864</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Ther. 2003 May;25(5):1503-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12867225</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001436 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001436 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:26471079
   |texte=   The Potential Role of Social Media Platforms in Community Awareness of Antibiotic Use in the Gulf Cooperation Council States: Luxury or Necessity?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:26471079" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021